Core Viewpoint - The securities industry is expected to experience significant growth due to a series of financial policies, with a focus on transformation and asset allocation capabilities becoming crucial for firms [1][2]. Group 1: Industry Outlook - Analysts predict a net profit growth exceeding 30% for the securities industry in the first half of 2024, with a continued positive trend into 2025 [2]. - The first quarter of 2025 is expected to see a year-on-year net profit increase of approximately 50% for 42 listed securities firms [2]. - The industry is projected to maintain a net profit growth rate of 37.7% in the first half of 2025, with annualized ROE expected to rise to 6% [2]. Group 2: Market Dynamics - Capital market reforms are creating new growth opportunities for the securities industry, with a total stock market value surpassing 100 trillion yuan and an increasing rate of securitization [3]. - Analysts have differing views on the current valuation of the securities sector, with some seeing it as undervalued while others believe it has returned to a reasonable level [3]. Group 3: Business Segmentation - The industry is experiencing significant operational differentiation, with self-operated and brokerage businesses becoming key performance drivers [4]. - The investment business is highlighted as a critical factor for annual performance, with a shift from simple expansion in fixed income to a focus on self-operated transformation [5][6]. Group 4: Strategic Directions - Analysts emphasize the need for enhanced strategy trading capabilities and cross-border asset allocation in fixed income, while high-dividend equity investments are becoming a consensus [5]. - The current low-interest-rate environment is constraining the capital gains potential in bond investments, leading to a focus on equity self-operation as a viable alternative [6].

Core Viewpoint - The article discusses the evolution and significance of the brokerage private fund custody business in China, highlighting its growth from inception to a trillion-dollar market, and emphasizing the role of custodians in safeguarding investor interests and enhancing industry stability [2][3][4]. Group 1: Development of Brokerage Private Fund Custody - The development of brokerage private fund custody is closely linked to the improvement of private fund regulations, with the new Fund Law in 2013 marking the beginning of this business [3]. - By the end of 2023, custodians managed a total of 139,400 private fund products with an asset scale of 18.82 trillion yuan, of which brokerages accounted for over 10,000 products and approximately 5.18 trillion yuan in assets [4]. Group 2: Regulatory Changes and Industry Standards - The introduction of the 2023 Private Fund Supervision Regulations and the 2024 Private Securities Investment Fund Operation Guidelines signifies a new phase of high-quality development in the private fund industry [5]. - The draft revision of the Securities Investment Fund Custody Business Management Measures aims to optimize the custody industry ecosystem and enhance the responsibilities of custodians [11]. Group 3: Competitive Landscape and Value Creation - Brokerages are adopting low-fee strategies in the private fund custody business, but the fixed costs associated with system construction and human resources make profitability challenging [6]. - Longjiang Securities suggests repositioning custody services from basic service providers to comprehensive service providers, enhancing the value chain through upgraded services [7]. Group 4: Integration of Services and Client Needs - Brokerages are expanding service offerings to include customized solutions for private fund clients, integrating various business segments to create a one-stop service experience [8][9]. - The establishment of funding platforms and hosting events for capital matching are part of the efforts to enhance service delivery and client engagement [9]. Group 5: Technological Advancements and AI Integration - The integration of AI technology in asset custody is transforming operational efficiency and risk management capabilities, enabling automated processes and real-time risk assessment [14][15]. - AI applications are enhancing customer service through intelligent systems that provide personalized experiences and improve client satisfaction [15]. Group 6: Risk Management and Industry Recommendations - The article emphasizes the need for a multi-dimensional risk identification system within custody institutions to address complexities in private fund management [16]. - Recommendations include enhancing the regulatory framework for private fund managers and improving information exchange mechanisms among industry participants to mitigate risks [17].

Core Insights - The introduction of general pledged repos for credit bond ETFs is expected to equalize the functional differences between credit bond ETFs and underlying assets, potentially lowering financing costs and enhancing investor returns [1][2]. Group 1: General Pledged Repo Implementation - Nine credit bond ETFs have received approval letters from China Securities Depository and Clearing Corporation, allowing them to be included in the repo collateral pool, with a total scale exceeding 70 billion yuan as of the end of May [1]. - The implementation of general pledged repos is anticipated to release policy dividends, further promoting the growth of credit bond ETFs [1][2]. Group 2: Mechanism and Risk Management - The standard bond system will be adopted for the general pledged repo, with collateral eligibility determined by bond type and rating, while the 2025 guidelines expand the scope but raise rating requirements [2]. - Daily mark-to-market pricing will be used for repo discount rates, and any adjustments in collateral eligibility or discount rates may necessitate timely replenishment of collateral to avoid shortfall risks [2]. Group 3: Benefits of Credit Bond ETFs - Using credit bond ETFs as collateral can enhance convenience and reduce the volatility of discount rates, thereby lowering pledge risks and overall financing costs [3]. - The frequency and magnitude of discount rate adjustments for credit bonds can lead to higher transaction costs during extreme market conditions, making ETFs a more stable option for collateral [3]. Group 4: Performance Differentiation Among Bond ETFs - Performance differentiation may occur among bond ETFs, even those tracking the same index, due to variations in underlying asset liquidity and management strategies [4]. - Index funds may adopt sampling replication methods and exhibit active management characteristics to address liquidity constraints, leading to potential deviations from the index [4].

Group 1 - The transaction involves Shanghai Aopumai Biotechnology Co., Ltd. acquiring 100% equity of Pengli Bio-pharmaceutical Technology (Shanghai) Co., Ltd. through a combination of issuing shares and cash payment [1][2] - The industry classification of the target company falls under "M73 Scientific Research and Technical Services" specifically within "4.1 Biopharmaceutical Industry" [1][2] - The transaction is categorized as a vertical merger within the same industry, enhancing the company's CRDMO (Cell Culture Medium + Clinical CRO + Biopharmaceutical CDMO) service capabilities [2][3] Group 2 - The transaction includes issuing shares to no more than 35 specific investors to raise supporting funds [3] - The independent financial advisor confirms that the listed company is not under investigation by the China Securities Regulatory Commission (CSRC) [3]

Core Viewpoint - The company, Shanghai Aopumai Biotechnology Co., Ltd., is planning to acquire 100% equity of Pengli Biological Technology (Shanghai) Co., Ltd. through a combination of issuing shares and cash payment, involving multiple investment partners [1][2]. Group 1: Transaction Details - The acquisition involves several investment entities, including PharmaLegacy Hong Kong Limited and various limited partnerships, indicating a broad consortium of investors [1]. - The company intends to raise supporting funds by issuing shares to no more than 35 specific investors as part of the transaction [1]. Group 2: Confidentiality Measures - The company has implemented strict confidentiality measures to prevent the leakage of sensitive information related to the transaction, including the establishment of a registration system for insider information [2]. - The independent financial advisor has confirmed that the company has adhered to relevant laws and regulations, ensuring effective confidentiality protocols are in place [2].

Group 1 - The independent financial advisor, Guotai Junan Securities Co., Ltd., conducted a review of Shanghai Aopumai Biotechnology Co., Ltd.'s acquisition and financing activities, confirming compliance with the relevant regulations [1][2] - The review found no instances of direct or indirect paid hiring of third parties by the independent financial advisor during the financial advisory process for the merger and acquisition [1][2] - The hiring of third-party institutions and individuals by the listed company was deemed legal and compliant with the regulations set forth by the China Securities Regulatory Commission [2] Group 2 - The listed company did not engage in any other direct or indirect paid hiring of third-party institutions or individuals beyond those mentioned [2] - The independent financial advisor's review opinion aligns with the regulations regarding the hiring of third parties in investment banking activities [2]

Core Viewpoint - The transaction by Shanghai Aopumai Biotechnology Co., Ltd. to acquire 100% equity of Pengli Bio-pharmaceutical Technology (Shanghai) Co., Ltd. through a combination of share issuance and cash payment does not constitute a major asset restructuring as per the relevant regulations [1][2][4]. Group 1: Transaction Details - The transaction involves the acquisition of 100% equity of Pengli Bio-pharmaceutical by issuing shares and cash to multiple investors [1][2]. - The company plans to raise supporting funds by issuing shares to no more than 35 specific investors [2]. Group 2: Regulatory Compliance - The independent financial advisor, Guotai Junan Securities Co., Ltd., conducted a review and confirmed that the transaction does not lead to a change in control of the company [4]. - The current controlling shareholder is Mr. Xiao Zhihua, and the actual controllers are Mr. Xiao and Mrs. He Yunfen, indicating stability in control post-transaction [4].

Core Summary - In 2025, the securities industry is expected to experience a dual increase in profitability and valuation due to favorable policies and liquidity support, with a focus on the improvement of brokerage services, proprietary asset allocation, and international business as sources of performance differentiation [4][5] Group 1: Policy and Liquidity Support - The major highlight for the securities sector in 2025 is the favorable policies and liquidity support, particularly the implementation of the "Plan to Promote Long-term Funds into the Market," which sets clear investment scale and ratio requirements for public funds, insurance funds, and pension funds [4][12] - The People's Bank of China implemented a "combination punch" of interest rate cuts and reserve requirement ratio reductions in May 2025, which is expected to drive residents' deposits and bank wealth management products towards equity assets [4][34] Group 2: Wealth Management - The trend of residents moving their deposits to equity assets is accelerating, supported by the new public fund regulations and the full rollout of the personal pension system, which is expected to bring incremental investments to public funds [4][32] - The public fund fee structure is being reformed to focus on investor returns, aiming to enhance the investment value and attract more long-term capital into the market [4][35] Group 3: Proprietary Business - The proprietary investment performance is expected to be differentiated due to regulatory restrictions on derivatives and limited space for bond market allocation, with equity allocation becoming the core of proprietary performance [4][21] - The securities firms are encouraged to increase their allocation to high-quality equity assets, while the fixed income segment is expected to shift from a "lying win" strategy to a more diversified "fixed income+" investment approach [4][5] Group 4: International Business - The internationalization of securities firms is seen as an inevitable trend, with large firms accelerating their global market penetration, particularly in Southeast Asia and the Middle East, driven by the demand for cross-border financing and mergers [4][5] - The regulatory environment is being optimized to create a market-oriented, legal, and international business environment, facilitating the expansion of international business for securities firms [4][5] Group 5: Investment Analysis - The overall outlook for the securities sector is positive, with expectations of profitability and valuation increases, driven by differentiated competition in proprietary investment, wealth management, and international expansion [4][5] - Recommended investment targets include leading firms with strong comprehensive capabilities, firms with significant earnings elasticity, and those with robust international business competitiveness [4][5]

国泰海通证券股份有限公司 关于 中科院成都信息技术股份有限公司发行股份 及支付现金购买资产并募集配套资金 暨关联交易 之部分限售股份解除限售的核查意见 独立财务顾问 （中国（上海）自由贸易试验区商城路 618 号） 签署日期：二〇二五年六月 国泰海通证券股份有限公司（以下简称"国泰海通证券"、"本独立财务顾问"） 作为中科院成都信息技术股份有限公司（以下简称"中科信息"、"上市公司"或"公 司"）发行股份及支付现金购买资产并募集配套资金暨关联交易（以下简称"本次 交易"）的独立财务顾问，根据《证券发行上市保荐业务管理办法》 《上市公司重 大资产重组管理办法》 《深圳证券交易所创业板股票上市规则》 《深圳证券交易所 上市公司自律监管指引第 2 号—创业板上市公司规范运作》等相关法律法规的 规定，对本次交易部分限售股份解除限售情况进行了审慎核查，具体核查情况如 下： 一、公司本次解除限售股份情况 （一）本次解除限售股份的发行及上市情况 管理委员会（以下简称"中国证监会"）于 2021 年 9 月 23 日出具的《关于同意中 科院成都信息技术股份有限公司向成都中科唯实仪器有限责任公司等发行股份 购买资产并募集配套资 ...

国泰海通证券股份有限公司 关于苏州市味知香食品股份有限公司 关于差异化权益分派特殊除权除息的业务申请的核查意见 国泰海通证券股份有限公司（以下简称"保荐机构"、"国泰海通"）作为 苏州市味知香食品股份有限公司（以下简称"味知香"、"公司"）持续督导的 保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所股票上市 《上海证券交易所上市公司自律监管指引第 7 号——回购股份》 规则》 《上海证券 交易所上市公司自律监管指南第 2 号——业务办理》等有关规定，就味知香差异 化权益分派特殊除权除息的业务申请事项进行了审慎核查，发表核查意见如下： 一、审议通过的差异化权益分派方案 公司将按照以下公式计算除权除息开盘参考价： 除权（息）参考价格=（前收盘价格-现金红利）÷（1+流通股份变动比例） 公司于 2025 年 4 月 25 日召开第三届董事会第六次会议审议通过了《关于公 司 2024 年度利润分配方案的议案》，公司 2024 年度拟以实施权益分派股权登记 日登记的总股本扣除公司回购专用证券账户股份为基数分配利润，公司拟向全体 股东（公司回购专用证券账户除外）每 10 股派送现金红利人民币 3.60 元（ ...